Equitec Specialists’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Equitec Specialists’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-40	Closed	-$265K	–	95
2015 Q1	$265K	Sell	40 -127	-76%	-$1.53M	0.07%	55
2014 Q4	$1.75M	Buy	+167	New	+$1.67M	0.45%	35

Other funds holding CANF

TAM

Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Equitec Specialists's CANF Position: Q2 2015 in Review

Equitec Specialists sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2015, closing a stake of 40 shares — an estimated $265K sold.

Equitec Specialists first reported a position in CANF in Q4 2014 and held it in 2 quarters. The position peaked at $1.75M in Q4 2014. 5 funds tracked by Wall St. Rank hold CANF as of Q2 2015.

Equitec Specialists reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2015 after selling out during the quarter.
Equitec Specialists sold 40 Can-Fite BioPharma American Depositary Shares shares in Q2 2015, an estimated $265K.
Equitec Specialists first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2014 and held it in 2 quarters.
Equitec Specialists's Can-Fite BioPharma American Depositary Shares position peaked at $1.75M in Q4 2014.
5 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2015.

Based on Equitec Specialists's 13F filing for Q2 2015, filed 5 Aug 2015.